Enveric Biosciences to Participate in Upcoming Investor Conferences in October 2021
10/07/2021 - 07:30 AM
NAPLES, Fla. , Oct. 7, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that Dr. Joseph Tucker , Chief Executive Officer of Enveric Biosciences, will participate in two upcoming October conferences:
A.G.P.'s Biotech & Specialty Pharma Conference to be held virtually on Wednesday, October 13, 2021 . KCSA Psychedelics Investor Conference to be held virtually at VirtualInvestorConferences.com from October 13-14, 2021 . Dr. Tucker will present live on Wednesday, October 13 th at 11:30 a.m. ET . Register to attend here . For more information about the conferences, or to schedule a one-on-one meeting with Enveric's management team, please contact your representatives directly, or send an email to A.G.P. at agpevents@allianceg.com or KCSA Strategic Communications at envericbio@kcsa.com .
About Enveric Biosciences Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more. For more information, please visit www.enveric.com .
Investor Contacts Valter Pinto / Allison Soss KCSA Strategic Communications 212.896.1254 / 212.896.1267valter@kcsa.com / asoss@kcsa.com
Media Contacts Raquel Cona / Joe McIntyre KCSA Strategic Communications 212.896.1204 / 856.381.8996rcona@kcsa.com / jmcintyre@kcsa.com
View original content:https://www.prnewswire.com/news-releases/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-october-2021-301394758.html
SOURCE Enveric Biosciences
ENVB Rankings
N/A Ranked by Stock Gains
ENVB Stock Data
Industry
Semiconductor and Related Device Manufacturing
Sector
Manufacturing
Country
US
City
Suwanee
About ENVB
ameri100 embodies a value system of ambition, mastery, excitement, reliability and integrity. with these values, the company is becoming an emerging global leader in sap technologies. ameri100, founded in 2013 has rapidly grown through strategic acquisitions. headquartered in princeton, new jersey, with offices in new york, georgia, kansas, pennsylvania, arizona, toronto- canada and bangalore, mumbai, chennai in india, ameri100 brings 500+ of its own best-in-class resources. the company has also evolved a unique partner ecosystem, which adds more than 4500+ resources to its delivery muscle power. ameri100 deals with sap enterprise services, digital transformation, cloud solutions, business intelligence & analytics, mobile applications and professional services. the company is also making strategic investments in artificial intelligence (ai), internet of things (iot) and robotic process automation (rpa). insight to impact!